Oral Glutamine in Preventing Treatment-Related Mucositis in Adult Patients with Cancer: A Systematic Review

Nutrition in Clinical Practice

Volumn 31, Issue 2, 2016, Pages 171-179

  Sayles, Caitlin ^a   Hickerson, Stephen C ^a   Bhat, Raksha R ^a   Hall, Jacob ^b   Garey, Kevin W ^a   Trivedi, Meghana V ^a  

^a UNIVERSITY OF HOUSTON   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

cancer; chemotherapy; esophagitis; glutamine; mucositis; radiation; stomatitis

Indexed keywords

GLUTAMINE;

ANOREXIA; BREAST CANCER; DIGESTIVE SYSTEM CANCER; DISEASE DURATION; ESOPHAGITIS; HEAD AND NECK CANCER; HEMATOLOGIC MALIGNANCY; HUMAN; LUNG CANCER; MEDLINE; MUCOSA INFLAMMATION; NAUSEA; NEOPLASM; REVIEW; SOLID TUMOR; STOMATITIS; SYSTEMATIC REVIEW; VOMITING; WEIGHT REDUCTION; XEROSTOMIA; COMPLICATION; FACTUAL DATABASE; MUCOSITIS; NEOPLASMS; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR;

ADMINISTRATION, ORAL; DATABASES, FACTUAL; GLUTAMINE; HUMANS; MUCOSITIS; NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS;

EID: 84962601533     PISSN: 08845336     EISSN: 19412452     Source Type: Journal    
DOI: 10.1177/0884533615611857     Document Type: Review

References (44)

1. Zur E,. Oral mucositis: etiology, and clinical and pharmaceutical management. Int J Pharm Compd. 2012; 16 (1): 22-33.
2. Palma DA, Senan S, Oberije C, et al. Predicting esophagitis after chemoradiation therapy for non-small cell lung cancer: an individual patient data meta-analysis. Int J Radiat Oncol Biol Phys. 2013; 87 (4): 690-696.
3. Gibson RJ, Keefe DM, Lalla RV, et al. Systematic review of agents for the management of gastrointestinal mucositis in cancer patients. Support Care Cancer. 2013; 21 (1): 313-326.
4. Davila M, Bresalier RS,. Gastrointestinal complications of oncologic therapy. Nat Clin Pract Gastroenterol Hepatol. 2008; 5 (12): 682-696.
5. Peterson DE, Jones JB, Petit RG II,. Randomized, placebo-controlled trial of Saforis for prevention and treatment of oral mucositis in breast cancer patients receiving anthracycline-based chemotherapy. Cancer. 2007; 109 (2): 322-331.
6. Sornsuvit C, Komindr S, Chuncharunee S, Wanikiat P, Archararit N, Santanirand P,. Pilot study: effects of parenteral glutamine dipeptide supplementation on neutrophil functions and prevention of chemotherapy-induced side-effects in acute myeloid leukaemia patients. J Int Med Res. 2008; 36 (6): 1383-1391.
7. Topkan E, Parlak C, Topuk S, Pehlivan B,. Influence of oral glutamine supplementation on survival outcomes of patients treated with concurrent chemoradiotherapy for locally advanced non-small cell lung cancer. BMC Cancer. 2012; 12: 502.
8. Rosenthal DI,. Consequences of mucositis-induced treatment breaks and dose reductions on head and neck cancer treatment outcomes. J Support Oncol. 2007; 5 (9)(suppl 4): 23-31.
9. Stiff P,. Mucositis associated with stem cell transplantation: current status and innovative approaches to management. Bone Marrow Transplant. 2001; 27 (suppl 2): S3-S11.
10. Sonis ST, Elting LS, Keefe D, et al. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer. 2004; 100 (9)(suppl): 1995-2025.
11. Keefe DM, Schubert MM, Elting LS, et al. Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer. 2007; 109 (5): 820-831.
12. Alvarino-Martin C, Sarrion-Perez MG,. Prevention and treatment of oral mucositis in patients receiving chemotherapy. J Clin Exp Dent. 2014; 6 (1): e74-e80.
13. Lalla RV, Bowen J, Barasch A, et al. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 2014; 120 (10): 1453-1461.
14. Yarom N, Ariyawardana A, Hovan A, et al. Systematic review of natural agents for the management of oral mucositis in cancer patients. Support Care Cancer. 2013; 21 (11): 3209-3221.
15. Worthington HV, Clarkson JE, Bryan G, et al. Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev. 2011;(4): CD000978.
16. Pytlik R, Benes P, Patorkova M, et al. Standardized parenteral alanyl-glutamine dipeptide supplementation is not beneficial in autologous transplant patients: a randomized, double-blind, placebo controlled study. Bone Marrow Transplant. 2002; 30 (12): 953-961.
17. Vanek VW, Matarese LE, Robinson M, Sacks GS, Young LS, Kochevar M,. A.S.P.E.N. position paper: parenteral nutrition glutamine supplementation. Nutr Clin Pract. 2011; 26 (4): 479-494.
18. Moher D, Liberati A, Tetzlaff J, Altman DG,. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009; 339: b2535.
19. Topkan E, Yavuz MN, Onal C, Yavuz AA,. Prevention of acute radiation-induced esophagitis with glutamine in non-small cell lung cancer patients treated with radiotherapy: evaluation of clinical and dosimetric parameters. Lung Cancer. 2009; 63 (3): 393-399.
20. Tutanc OD, Aydogan A, Akkucuk S, et al. The efficacy of oral glutamine in prevention of acute radiotherapy-induced esophagitis in patients with lung cancer. Contemp Oncol (Pozn). 2013; 17 (6): 520-524.
21. Gul K, Muge A, Taner A, Sehri E,. Oral glutamine supplementation reduces radiotherapy- induced esophagitis in lung cancer patients. Asian Pac J Cancer Prev. 2015; 16 (1): 53-58.
22. Cockerham MB, Weinberger BB, Lerchie SB,. Oral glutamine for the prevention of oral mucositis associated with high-dose paclitaxel and melphalan for autologous bone marrow transplantation. Ann Pharmacother. 2000; 34 (3): 300-303.
23. Li Y, Yu Z, Liu F, Tan L, Wu B, Li J,. Oral glutamine ameliorates chemotherapy-induced changes of intestinal permeability and does not interfere with the antitumor effect of chemotherapy in patients with breast cancer: a prospective randomized trial. Tumori. 2006; 92 (5): 396-401.
24. Chattopadhyay S, Saha A, Azam M, Mukherjee A, Sur PK,. Role of oral glutamine in alleviation and prevention of radiation-induced oral mucositis: a prospective randomized study. South Asian J Cancer. 2014; 3 (1): 8-12.
25. Tsujimoto T, Yamamoto Y, Wasa M, et al. L-glutamine decreases the severity of mucositis induced by chemoradiotherapy in patients with locally advanced head and neck cancer: a double-blind, randomized, placebo-controlled trial. Oncol Rep. 2015; 33 (1): 33-39.
26. Vidal-Casariego A, Calleja-Fernandez A, Ballesteros-Pomar MD, Cano-Rodriguez I,. Efficacy of glutamine in the prevention of oral mucositis and acute radiation-induced esophagitis: a retrospective study. Nutr Cancer. 2013; 65 (3): 424-429.
27. Jebb SA, Osborne RJ, Maughan TS, et al. 5-Fluorouracil and folinic acid-induced mucositis: no effect of oral glutamine supplementation. Br J Cancer. 1994; 70 (4): 732-735.
28. Coghlin Dickson TM, Wong RM, et al. Effect of oral glutamine supplementation during bone marrow transplantation. JPEN J Parenter Enteral Nutr. 2000; 24 (2): 61-66.
29. Choi K, Lee SS, Oh SJ, et al. The effect of oral glutamine on 5-fluorouracil/leucovorin-induced mucositis/stomatitis assessed by intestinal permeability test. Clin Nutr. 2007; 26 (1): 57-62.
30. Skubitz KM, Anderson PM,. Oral glutamine to prevent chemotherapy induced stomatitis: a pilot study. J Lab Clin Med. 1996; 127 (2): 223-228.
31. Okuno SH, Woodhouse CO, Loprinzi CL, et al. Phase III controlled evaluation of glutamine for decreasing stomatitis in patients receiving fluorouracil (5-FU)-based chemotherapy. Am J Clin Oncol. 1999; 22 (3): 258-261.
32. Fox AD, Kripke SA, De Paula J, Berman JM, Settle RG, Rombeau JL,. Effect of a glutamine-supplemented enteral diet on methotrexate-induced enterocolitis. JPEN J Parenter Enteral Nutr. 1988; 12 (4): 325-331.
33. Ziegler TR, Benfell K, Smith RJ, et al. Safety and metabolic effects of L-glutamine administration in humans. JPEN J Parenter Enteral Nutr. 1990; 14 (4)(suppl): 137S-146S.
34. Bartlett DL, Charland S, Torosian MH,. Effect of glutamine on tumor and host growth. Ann Surg Oncol. 1995; 2 (1): 71-76.
35. Johnson DJ, Jiang ZM, Colpoys MF, Kapadia CR, Smith RJ, Wilmore DW,. Glutamine infusion supports plasma amino acid metabolism during simulated stress. Curr Surg. 1986; 43 (1): 31-34.
36. Klimberg VS, Souba WW, Dolson DJ, et al. Prophylactic glutamine protects the intestinal mucosa from radiation injury. Cancer. 1990; 66 (1): 62-68.
37. Luo Y, Yoneda J, Ohmori H, et al. Cancer usurps skeletal muscle as an energy repository. Cancer Res. 2014; 74 (1): 330-340.
38. Medina MA,. Glutamine and cancer. J Nutr. 2001; 131 (9)(suppl): 2539S-2551S.
39. Yoshida S, Kaibara A, Ishibashi N, Shirouzu K,. Glutamine supplementation in cancer patients. Nutrition. 2001; 17 (9): 766-768.
40. Collins CL, Wasa M, Souba WW, Abcouwer SF,. Determinants of glutamine dependence and utilization by normal and tumor-derived breast cell lines. J Cell Physiol. 1998; 176 (1): 166-178.
41. Sauer LA, Dauchy RT,. Ketone body, glucose, lactic acid, and amino acid utilization by tumors in vivo in fasted rats. Cancer Res. 1983; 43 (8): 3497-3503.
42. Rouse K, Nwokedi E, Woodliff JE, Epstein J, Klimberg VS,. Glutamine enhances selectivity of chemotherapy through changes in glutathione metabolism. Ann Surg. 1995; 221 (4): 420-426.
43. Rubio IT, Cao Y, Hutchins LF, Westbrook KC, Klimberg VS,. Effect of glutamine on methotrexate efficacy and toxicity. Ann Surg. 1998; 227 (5): 772-780.
44. Klimberg VS, Nwokedi E, Hutchins LF, et al. Glutamine facilitates chemotherapy while reducing toxicity. JPEN J Parenter Enteral Nutr. 1992; 16 (6)(suppl): 83S-87S.